Novartis Investigative Site

Miami Lakes, Florida 33014

0 studies enrolling now · 8 studies all time

What they study most

Chronic Heart Failure, Chronic Kidney Disease (CKD), Diabetes Mellitus, Type 2, Diabetic Nephropathy, Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Sarcopenia, Tendinopathy

Studies at this site

• Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) — Stopped early
• Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy — Completed
• Study of Efficacy, Safety and Tolerability of AIN457 in Patients With Active Overuse Tendinopathy — Completed
• Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function — Completed
• Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes — Completed
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed